Trump's Cancer Research Cuts Jeopardize Moonshot | JQJO

The Trump administration's actions have significantly hampered US cancer research. Funding cuts and grant terminations, particularly targeting programs with keywords like "trans," "diverse," and "women," have disrupted the Cancer Moonshot initiative. The NIH, CDC, and Department of Defense have experienced substantial funding reductions, impacting clinical trials and potentially delaying new treatments. While some grants have been reinstated by courts, the damage to research and researchers remains significant, jeopardizing progress toward reducing cancer deaths.